Arrivent BioPharma, Inc. (AVBP)
29.79
-0.49
(-1.62%)
USD |
NASDAQ |
Sep 09, 16:00
29.84
+0.06
(+0.18%)
After-Hours: 20:00
Arrivent BioPharma EPS Diluted (Quarterly) : -1.048 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.048 |
| March 31, 2026 | -0.9612 |
| December 31, 2025 | -0.8373 |
| September 30, 2025 | -0.8345 |
| June 30, 2025 | -0.897 |
| March 31, 2025 | -1.891 |
| December 31, 2024 | -0.6121 |
| September 30, 2024 | -0.6103 |
| Date | Value |
|---|---|
| June 30, 2024 | -0.6528 |
| March 31, 2024 | -0.52 |
| December 31, 2023 | -0.6327 |
| September 30, 2023 | -0.43 |
| June 30, 2023 | -0.6439 |
| March 31, 2023 | -0.3634 |
| December 31, 2022 | -0.3118 |
| September 30, 2022 | -0.3514 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cytokinetics, Inc. | -1.505 |
| Gilead Sciences, Inc. | -8.444 |
| Ionis Pharmaceuticals, Inc. | -0.6931 |
| Vertex Pharmaceuticals, Inc. | 4.310 |
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -49.89M |
| Total Expenses (Quarterly) | 49.89M |
| Enterprise Value | 1.067B |
| Earnings Yield | -12.36% |
| Normalized Earnings Yield | -12.36 |